Clinical Trials Logo

First Episode Psychosis clinical trials

View clinical trials related to First Episode Psychosis.

Filter by:

NCT ID: NCT01157559 Completed - Clinical trials for First Episode Psychosis

Efficacy and Safety With Ziprasidone in First-episode Psychosis

Start date: n/a
Phase: Phase 4
Study type: Interventional

The aim of the study is to investigate the efficacy and safety of ziprasidone in patients with first episode psychosis.

NCT ID: NCT01026584 Completed - Clinical trials for First Episode Psychosis

Efficacy and Safety of Aripiprazole in First Episode Psychosis

Start date: October 2009
Phase: Phase 4
Study type: Interventional

The aim of the study is to investigate the efficacy and safety of aripiprazole in patients with first episode psychosis.

NCT ID: NCT00916461 Completed - Clinical trials for First Episode Psychosis

Role of Minocycline in First Episode Psychosis

Start date: May 2006
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether the addition of minocycline or placebo to treatment as usual (TAU): 1. prevents the accumulation of negative symptoms and intellectual decline following a first episode of non-affective psychosis; and 2. whether minocycline stabilizes the efficacy of antipsychotics.

NCT ID: NCT00202280 Completed - Clinical trials for First Episode Psychosis

Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication

Start date: September 2004
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether Vitamin B12,B6 and Folic Acid are effective with antipsychotic medication in the treatment of First Episode Psychosis.The B-complex Vitamins' homocysteine lowering properties may have an effect on cognition and symptoms. We are examining changes in symptoms and cognition over a 3 month period.